Social Media

The NHS continues to miss key cancer waiting times, as new figures showed a third of patients in one health board area had to wait more than two months for treatment to get underway. NHS data showed that from July to September 87.2% of all cancer patients across Scotland started…
A new treatment which can halt the spread of breast cancer for up to two years for terminally ill patients has been approved for use by the NHS in Scotland. Campaigners welcomed the Scottish Medicines Consortium (SMC)'s backing for the drug palbociclib, hailing it as a "wonderful decision" and "great…
A radical new immune therapy developed from cases of "miraculous" cancer recovery could be tested on patients as early as next year. Scientists have found a way to screen potent cancer-killing immune cells from donor blood and multiply them by the million. The neutrophil cells form part of the body's…
Edge Hill University has received funding from the National Institute for Health Research to review the provision of respite care for young adults with life limiting conditions or complex needs. The research team, led by Sally Spencer, Professor of Clinical Research in the University’s Postgraduate Medical Institute, has received £168,554…
Public sector organisations are being driven to produce greater efficiencies and cost savings, and the NHS in particular is facing the requirement to do more with less, and deliver better and more effective care while at the same time reducing a fiscal deficit. This economic challenge has been the catalyst…
A new project to transform the aftercare and improve the quality of life for cancer survivors is being delivered by Sheffield Hallam University thanks to a £2.5million funding award by the National Institute for Health Research (NIHR). Led by Queen Mary University of London (QMUL), Barts Health NHS Trust and…
Thousands of women with previously untreatable breast cancer have been given new hope after health officials approved two new "breakthrough" drugs for NHS use. In new draft guidance, the National Institute for Health and Care Excellence (Nice) has approved palbociclib and ribociclib for widespread use in the health service in…
Strokes are costing the UK £26 billion annually and this could triple within 20 years if action is not taken, charity figures suggest. A new report by the Stroke Association found that strokes are taking a financial toll three times higher than the previous estimate in 2009. Researchers believe the…
Page 1 of 10